Blue Bonnet is a modern hybrid-indica strain derived directly from Blueberry. Cultivators can expect a moderate difficulty level when growing this plant, which is suitable for both indoor and outdoor environments. The strain reaches maturity following a 65-day flowering period and is recognized for producing high yields. Its genetic influence is widespread in contemporary breeding, serving as the parent for a diverse array of offspring including Blisterene, Blou Gehrig, Blubba Kush, Blue Hashplant, Blue Sour, Blueberry IX/IC, Blueberry Vodka, Bluperskunk, Broken N8tive, Bubbleberry V2, Cherry Berry, and Eyescream Bananas.

The chemical profile of Blue Bonnet is characterized by a complex terpene hierarchy led by myrcene, terpinolene, and caryophyllene, followed by limonene, ocimene, linalool, humulene, pinene, beta-pinene, bisabolol, guaiol, alpha-terpinene, nerolidol, and camphene. This specific sequence of volatile compounds defines the sensory experience, grounding the high concentration of THC in a nuanced aromatic structure. The interaction between these terpenes contributes to the strain's distinct profile, where the primary myrcene foundation is complemented by the secondary terpinolene and tertiary caryophyllene notes, tapering through the subsequent list of minor constituents.

As a THC-dominant variety, Blue Bonnet is primarily utilized for its therapeutic potential in managing pain, stress, and sleep. Users report a consistent effects profile that promotes a state of being relaxed, calm, and focused. This combination of mental clarity and physical tranquility makes it a functional choice for those seeking relief without total sedation. Through its expansive list of notable offspring, the lineage of Blue Bonnet remains a significant component of modern cannabis breeding programs.